Atlas Trials

Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study

Clinical trial NCT07695636 · COMPLETED

Trial details

NCT number
NCT07695636
Sponsor
IRCCS San Raffaele
Status
COMPLETED
Study type
OBSERVATIONAL
Ulcerative Colitis (UC)
Start date
2024-01-01
Primary completion
2026-01-01
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.